VSL#3® Probiotic Shown Effective in Dietary Management of Children With Irritable Bowel Syndrome
‘It was a lightbulb moment,’ says Claire, from Billingshurst, West Sussex. Confessions of a workaholic: A stark warning form a City high flyer whose obsession with her demanding career led her to the brink… The symptoms of IBS are triggered when muscles in the large intestine become sensitised and contract. The underlying cause is unknown, but stress can be a trigger. ‘I realised Elliott’s problems had coincided with him starting full-time at school,’ says Claire. ‘He didn’t get on with his new teacher and that’s when it began. ‘Yet when we’d gone to Portugal in the school holidays, the symptoms disappeared. ‘It was a relief to realise that Elliott didn’t have some horrible illness, but a shock to find out there was no cure.’ While as many as one adult in three will suffer from IBS at some point, many don’t realise children can also be affected. Indeed, one study suggested that 20 per cent of children suffer from IBS symptoms. The peak ages are from four to 12. So how can parents tell if their child has a simple tummy ache or IBS? Surprising: The second most cited cause for school absence is IBS ‘Most children will have bowel upsets and tummy aches when they’re having a stressful time but it usually goes away,’ says Professor Nick Read, a gastroenterologist and adviser to the IBS Network.
Pediatric Irritable Bowel Syndrome Medication
Using this high concentration of several different strains of specially selected beneficial bacteria, VSL#3 provides an optimal composition of good bacteria, enhancing the health of the GI tract and aiding in dietary management of IBS. Each packet of VSL#3 contains 450 billion CFU. VSL#3 is a registered trademark of VSL Pharmaceuticals Inc. VSL#3 is a product that has been licensed from VSL Pharmaceuticals Inc. to Sigma-Tau Pharmaceuticals, Inc. for the U.S. territory. For more information, visit http://www.vsl3.com . About Sigma-Tau Pharmaceuticals, Inc. Sigma-Tau Pharmaceuticals, Inc. is a U.S.-based, wholly owned subsidiary of the sigma-tau Group, and is dedicated solely to the global development and commercialization of medicines for patients with rare diseases.
what google did to me http://www.reuters.com/article/2010/08/16/idUS104326+16-Aug-2010+PRN20100816